Monday, June 16, 2025
21.6 C
Bengaluru

Interview with Salil Kallianpur

[wpfilebase tag=file id=95 tpl=download-button /]

Inside this Issue

1. Interview with Salil Kallianpur  with Anup Soans, Editor – MedicinMan

“There is much work to be done and a unified pharma industry can prove to be a valuable ally to the government.”

2. Patient-centricity: How Pharma Can Move from Intention to Action by Hanno Wolfram

Patient-centricity begins with moving from talking about the patient to talking to the patient 

3. The Corporate Halo Effect by Vivek Hattangadi

How a great corporate brand elevates a company’s products in the minds of doctors and patients

4. For a Positive Attitude, Clean Your Mind’s Windows  by Asheesh Kumar Patel

A bad attitude is a learned behavior and can be unlearned when we discover it’s source

5. The Three Transformations for Leadership  by Srinivasan Athmanathan

Three key professional traits that every successful leader must possess

6. Book Review: Feather in a C.A.P. by Kamalesh Subramanian 

A corporate saga with valuable lessons for professionals of all backgrounds

Hot this week

Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma

https://www.pharmamanufacturing.com/articles/2011/095 A quiet but seismic shift is underway in global...

Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?

A quiet but revolutionary milestone may be unfolding in...

AI and the Future of Pharma Field Sales: Boon or Bane?

India’s pharmaceutical industry runs on the strength of its...

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

Topics

Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma

https://www.pharmamanufacturing.com/articles/2011/095 A quiet but seismic shift is underway in global...

Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?

A quiet but revolutionary milestone may be unfolding in...

AI and the Future of Pharma Field Sales: Boon or Bane?

India’s pharmaceutical industry runs on the strength of its...

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
spot_img

Related Articles

spot_imgspot_img